Dipeptidyl Peptidase IV as a Potential Target for Selective Prodrug Activation and Chemotherapeutic Action in Cancers

[Image: see text] The efficacy of chemotherapeutic drugs is often offset by severe side effects attributable to poor selectivity and toxicity to normal cells. Recently, the enzyme dipeptidyl peptidase IV (DPPIV) was considered as a potential target for the delivery of chemotherapeutic drugs. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahan, Arik, Wolk, Omri, Yang, Peihua, Mittal, Sachin, Wu, Zhiqian, Landowski, Christopher P., Amidon, Gordon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255727/
https://www.ncbi.nlm.nih.gov/pubmed/25365774
http://dx.doi.org/10.1021/mp500483v

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255727/
https://www.ncbi.nlm.nih.gov/pubmed/25365774
http://dx.doi.org/10.1021/mp500483v

Ejemplares similares